Two patients in New York City were taken off ventilators taken out of intensive care after they received the experimental drug leronlimab.
At least two of seven patients on leronlimad saw significant improvement.
Advertisement - story continues below
This follows the news on Friday that the renowned French epidemiologist Dr. Didier Raoult was able to repeat his findings from a previous study on the use of hdroxychloroquine on coronavirus patients.
The New York Post reported:
Two coronavirus patients in New York City are off ventilators and out of intensive care after they received an experimental drug to treat HIV and breast cancer.
As the skyrocketing number of cases stretches city hospitals to the limit, doctors are racing to find out which drugs on the market or in development might help in fighting the infection.
The drug, leronlimab, is delivered by injection twice in the abdomen, the Daily Mail reported.
Of seven critically ill patients who received the drug in New York, two were removed from ventilators and two showed significant improvement.
Doctors right now don’t know quite how leronlimab works, but studies suggest it calms the overly aggressive immune response.